These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10433852)

  • 101. Analysis of limited proteolytic activity of calpain-7 using non-physiological substrates in mammalian cells.
    Maemoto Y; Kiso S; Shibata H; Maki M
    FEBS J; 2013 Jun; 280(11):2594-607. PubMed ID: 23497113
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Modelling post-mortem tenderisation-IV: Role of calpains and calpastatin in conditioning.
    Dransfield E
    Meat Sci; 1993; 34(2):217-34. PubMed ID: 22060665
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Degradation of actin and vimentin by calpain II, a Ca2+-dependent cysteine proteinase, in bovine lens.
    Yoshida H; Murachi T; Tsukahara I
    FEBS Lett; 1984 May; 170(2):259-62. PubMed ID: 6327382
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Association between plasma membrane (Ca+Mg) ATPase and calpain/calpastatin system in rat erythrocytes.
    Soldati L; Vezzoli G; Salardi S; Spaventa R; Barber BR; Azzani T; Bianchi G
    Biochem Biophys Res Commun; 1996 May; 222(2):572-5. PubMed ID: 8670246
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Calpain and calpastatin in rabbit corneal epithelium.
    Shearer TR; Azuma M; David LL; Yamagata Y; Murachi T
    Curr Eye Res; 1990 Jan; 9(1):39-44. PubMed ID: 2311414
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Selenite nuclear cataract: review of the model.
    Shearer TR; Ma H; Fukiage C; Azuma M
    Mol Vis; 1997 Jul; 3():8. PubMed ID: 9238097
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Immunoreactivities of m-calpain, calpastatin, nitric oxide synthase, myelin basic protein and dynamin II in baker's yeast, wheat germ and lobster tail muscle.
    Kuo WN; Jn-Baptiste JB; Kanadia RN; McNabb LD; Zhai L; Weeks K; Dopson N; Chambers MC
    Cytobios; 1996; 87(351):251-63. PubMed ID: 9214726
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Cysteine protease inhibitor E64 reduces the rate of formation of selenite cataract in the whole animal.
    Azuma M; David LL; Shearer TR
    Curr Eye Res; 1991 Jul; 10(7):657-66. PubMed ID: 1914502
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Extra-lysosomal proteolysis and expression of calpains and calpastatin in cultured thyroid cells.
    Karlsson JO; Nilsson M
    Cell Biol Int; 1997 Mar; 21(3):167-74. PubMed ID: 9151993
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A new model for assessing proteolysis in the intact mouse lens in organ culture.
    Petersen A; Zetterberg M; Sjöstrand J; Karlsson JO
    Ophthalmic Res; 2004; 36(1):25-30. PubMed ID: 15007236
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Structure-Based Virtual Screening and Biological Evaluation of a Calpain Inhibitor for Prevention of Selenite-Induced Cataractogenesis in an in Vitro System.
    Muralidharan AR; Selvaraj C; Singh SK; Sheu JR; Thomas PA; Geraldine P
    J Chem Inf Model; 2015 Aug; 55(8):1686-97. PubMed ID: 26270943
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Calpain-calpastatin: a novel, complete calcium-dependent protease system in human spermatozoa.
    Rojas FJ; Brush M; Moretti-Rojas I
    Mol Hum Reprod; 1999 Jun; 5(6):520-6. PubMed ID: 10340998
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Immunogold ultrastructural localization of calpastatin, the calpain inhibitor, in rabbit skeletal muscle.
    Nori SL; Pompili E; De Santis E; De Renzis G; Bondi A; Collier WL; Ippoliti F; Fumagalli L
    Cell Mol Biol (Noisy-le-grand); 1993 Nov; 39(7):729-37. PubMed ID: 8268759
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A new rat model for studying the calpain-calpastatin system.
    Soldati LP; Barber BR; Salardi S; Molinari I; Bianchi G
    Lab Anim; 1995 Oct; 29(4):420-6. PubMed ID: 8558825
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization.
    Ma H; Fukiage C; Kim YH; Duncan MK; Reed NA; Shih M; Azuma M; Shearer TR
    J Biol Chem; 2001 Jul; 276(30):28525-31. PubMed ID: 11375982
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Protease inhibitors in mouse skeletal muscle: tissue-associated components of serum inhibitors and calpastatin.
    Fumagalli L; Businaro R; Nori SL; Toesca A; Pompili E; Evangelisti E; Giannetti S; Ippoliti F; De Renzis G
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):535-46. PubMed ID: 8828909
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Altered calpastatin protein levels following traumatic brain injury in rat.
    Newcomb JK; Pike BR; Zhao X; Banik NL; Hayes RL
    J Neurotrauma; 1999 Jan; 16(1):1-11. PubMed ID: 9989462
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.
    Moldoveanu T; Gehring K; Green DR
    Nature; 2008 Nov; 456(7220):404-8. PubMed ID: 19020622
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Exploration of cornea permeable calpain inhibitors as anticataract agents.
    Nakamura M; Yamaguchi M; Sakai O; Inoue J
    Bioorg Med Chem; 2003 Apr; 11(7):1371-9. PubMed ID: 12628663
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Domain structure of calpain: mapping the binding site for calpastatin.
    Croall DE; McGrody KS
    Biochemistry; 1994 Nov; 33(45):13223-30. PubMed ID: 7947729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.